Leukemia, Hairy CellPentostatinArabinonucleosidesLeukemia, Lymphocytic, Chronic, B-CellAminosalicylic AcidsAntineoplastic AgentsVidarabineRemission InductionLeukemia, ProlymphocyticDrug Administration ScheduleChlorambucilInfusions, IntravenousWaldenstrom MacroglobulinemiaSplenectomyPoland2-ChloroadenosineRetreatmentAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeAntibodies, Monoclonal, Murine-DerivedAdministration, OralBenzenesulfonatesAdenine NucleotidesCyclophosphamideDrug Screening Assays, AntitumorDaunorubicinLymphoma, Non-HodgkinRecurrenceNeutropeniaPrednisoneCytarabineImmunosuppressive AgentsSurvival RateNeoplasm, ResidualCladribineInhibitory Concentration 50Injections, SubcutaneousLymphoma, B-CellThrombocytopeniaLeukemia, Myeloid, AcuteDrug Resistance, NeoplasmInterferonsNeoplasms, Second PrimaryTreatment FailureRadiation DosageLethal Dose 50VincristineDisease-Free SurvivalApoptosisFollow-Up StudiesDrug SynergismRadiometrySurvival AnalysisDisease ProgressionNeoplasm StagingNeoplasm Recurrence, LocalProspective StudiesNeoplasm ProteinsRetrospective StudiesTime FactorsDose-Response Relationship, RadiationDose FractionationRadiotherapy DosageDose-Response Relationship, DrugDouble-Blind MethodInjections, IntravenousArea Under CurveRadiotherapy Planning, Computer-AssistedHalf-LifeBody BurdenThermoluminescent DosimetryRats, Sprague-DawleyDrug InteractionsRelative Biological EffectivenessDrug Therapy, CombinationBiological AvailabilityNeoplasmsMetered Dose InhalersRadiation MonitoringMetabolic Clearance RateRadiation InjuriesDrug EvaluationRadiotherapy, Intensity-ModulatedRats, WistarLiverDisease Models, AnimalInjections, IntramuscularPhantoms, ImagingInjections, IntraperitonealDrug CombinationsAdministration, InhalationRadioisotopesBody WeightIodine RadioisotopesOrgans at RiskDose-Response Relationship, ImmunologicDogsRandom AllocationBlood PressureAntibodies, Monoclonal